Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: A multi-center cooperative study
- 1 August 1992
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 167 (2) , 481-486
- https://doi.org/10.1016/s0002-9378(11)91433-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Danazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human MonocytesAmerican Journal of Reproductive Immunology, 1990
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastageAmerican Journal of Obstetrics and Gynecology, 1989
- Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesisJournal of Steroid Biochemistry, 1989
- Anticardiolipin antibodies in unselected autoimmune rheumatic disease patientsClinical Immunology and Immunopathology, 1987
- Anticardiolipin antibodies in patients with rheumatic diseasesArthritis & Rheumatism, 1987
- Danazol Therapy for Autoimmune Hemolytic AnemiaAnnals of Internal Medicine, 1985
- Accentuated cyclic activation of peritoneal macrophages in patients with endometriosisAmerican Journal of Obstetrics and Gynecology, 1984
- Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytesNature, 1977
- Treatment of Hereditary Angioedema with DanazolNew England Journal of Medicine, 1976